Related Experiment Video
Updated: Oct 16, 2025

09:25
Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
11.5K
Metabolic reprogramming in epithelial ovarian cancer
Chalaithorn Nantasupha1, Chanisa Thonusin2,3,4, Kittipat Charoenkwan1
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University Chiang Mai, Thailand.
American Journal of Translational Research
|October 15, 2021
Summary
Cancer cells reprogram metabolism for growth. This review explores energy metabolism in ovarian cancer, focusing on glycolysis and oxidative phosphorylation (OXPHOS) for targeted therapy development.
Area of Science:
- Oncology
- Cancer Metabolism
- Biochemistry
Background:
- Cancer cells exhibit metabolic adaptations crucial for growth, invasion, and metastasis.
- Reprogramming of cellular energy metabolism is a central theme in cancer research and therapeutic strategies.
- While aerobic glycolysis (Warburg effect) was considered dominant, oxidative phosphorylation (OXPHOS) is increasingly recognized in certain cancer types.
Purpose of the Study:
- To comprehensively review current knowledge on energy metabolism in epithelial ovarian cancer.
- To investigate the roles of glycolysis and OXPHOS in ovarian cancer progression and chemoresistance.
- To provide insights for developing novel targeted therapies as adjuncts to standard chemotherapy.
Main Methods:
- Literature review of existing reports on ovarian cancer metabolism.
- Analysis of studies investigating glycolysis and OXPHOS pathways.
- Examination of chemoresistant cell lines and their metabolic profiles.
Main Results:
- Epithelial ovarian cancer exhibits metabolic heterogeneity, with varying preferences for glycolysis and OXPHOS.
- Glycolysis is generally considered the primary energy source for ovarian cancer growth, invasion, migration, and survival.
- Chemoresistant ovarian cancer cell lines display diverse metabolic strategies, complicating targeted interventions.
Conclusions:
- Understanding the metabolic plasticity of ovarian cancer is critical for effective treatment.
- Targeting glycolysis or OXPHOS pathways holds potential for attenuating tumor progression.
- Developing novel adjunctive therapies based on metabolic insights may reduce ovarian cancer mortality.
Related Concept Videos
Hormonal Control of the Ovarian Cycle
4.8K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
4.8K
Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K

